Chiklita ad
Showing posts with label Receptor. Show all posts
Showing posts with label Receptor. Show all posts
Tuesday, 20 February 2018
How insulin receptor works
The researchers from the Paul Langerhans Institute Dresden of the Helmholtz Zentrum München at the University Hospital Carl Gustav Carus of TU Dresden together with colleagues from Rockefeller University New York succeeded for the first time in the visualization of the insulin receptor activation.
Insulin exerts multiple effects on cellular metabolism and growth. The biological actions of insulin are mediated by a cell-surface receptor, called insulin receptor, which is present on the surface, i.e. the plasma membrane, of virtually all mammalian cells. The dysfunction of insulin receptor has been linked to severe pathologies including diabetes mellitus or cancer. Insulin binds outside the cell to the extracellular domain of its receptor and induces a structural change that is propagated across the membrane to the intracellular kinase domains inside the cell, causing them to activate each other, thus initiating signaling cascades.
The nature of this structural change remained a mystery for decades, resulting in mutually exclusive models for insulin receptor activation being put forward. To obtain insights into receptor activation, researchers purified full-length insulin receptors and embedded them into nanodiscs, which are nanoscale disc-shaped membrane patches. Those could then be directly visualized by single-particle electron microscopy.
This technology enables researchers to directly study the cell-surface receptors in an artificial membrane environment. In the absence of insulin, the receptor displays an inverted U-shaped ectodomain, which is consistent with previous crystallographic studies of isolated ectodomains, implying that the membrane-passing transmembrane domains and thus kinase domains are held well apart from each other. Upon insulin binding, the ectodomain of the receptor undergoes a dramatic reorganization, changing from a U-shaped to a T-shaped structure and also causing a rearrangement of the transmembrane domains. These now come together likely facilitating kinase domain interactions and thus their activation.
These nanodisc-embedded receptors provide a novel platform to address further questions regarding insulin receptor regulation and eventually to test therapeutic agents. The results directly demonstrate the structural transition in the full-length receptor upon insulin binding and offer an answer to the longstanding question concerning the mechanism by which insulin activates its receptor, thus improving understanding of the receptor.
haleplushearty.blogspot.com
Sunday, 11 June 2017
How to prevent premature labour
The bitter taste receptors that was found on uterine muscle could be use to examined the onset of labor, both at term and preterm.
Researchers attached strips of human and mouse uterine myometrium tissue to a machine that measured their contraction efforts.
The researchers first exposed the tissue to native hormones such as oxytocin and chemical compounds to make it contract, mimicking normal or premature labor.
They then exposed the tissue to bitter substances. Activating bitter taste receptors in the uterus relaxed the contracted uterine muscle tissue totally than the use of drugs.
The researchers also discovered that giving mice bitter substances before they showed any premature contractions prevented them from having early deliveries. This can also prevents preterm labour in human.
haleplushearty.blogspot.com
Wednesday, 26 April 2017
Chili peppers may reduce gut inflammation
Capsaicin is an active component of chili peppers that give them heat to targets a receptor in the gut and produces anandamide.
Anandamide produced by capsaicin reduces inflammation in the guts of mice, it summonings anti-inflammatory immune cells and reverse type 1 diabetes in rodents.
Chilli peppers and edible marijuana may provide treatment for type 1 diabetes and inflammation of the colon.
Capsaicin in chilli pepper attacks and attach to a receptor known as TRPVI that is present in gastrointestinal cells and produce more anandamide.
Sunday, 16 April 2017
New methods make cells resistant to HIV
Scientists at Scripps Research Institute have discovered a way to tie HIV-fighting antibodies to immune cells, producing a cell population resistant to the virus.
The latest experiment shows that resistance cells can replace disease cells quickly and curing the disease in HIV positive patients.
The new TSRI method is better than therapies where the antibodies float freely in the bloodstream at low concentration.
Antibodies in the new method hang on to a cell's surface, preventing HIV from entering cell receptor and spreading infection.
Scientists used rhinovirus as a model, they used lentivirus to deliver a new gene to cultured human cells.
The gene directed cells to produce antibodies that joined with the human cell receptor ICAM-1 that rhinovirus needs, this prevent virus from entering the cell to spread infection.
Researchers tested the same method against HIV. Strains of HIV joined with a cell surface receptor-CD4 on the immune cell that HIV normally kill.
Scientists confirmed that the antibodies prevent HIV in a better way than free-floating, HIV is treatable but not curable.
Labels:
Antibodies,
Bloodstream,
CD4,
Cells,
Experiment,
Gene,
Infection,
Receptor,
Rhinovirus,
virus
Sunday, 26 March 2017
Dogs can detect cancer
After six months of training, German Shepherds dogs detect breast cancer accurately.
Dogs exhale five minutes in one second to pull, inhale and deliver aromas that are decoded by their 300 million receptor cells.
Breast cancer have special smell that dogs can detect, Jacky Experton trained German Shepherds Thor and Nykios to recognise cancerous and non -cancerous rags.
Dogs detected cancerous cells because they have more nerve cells than human, they also pick variety of chemicals.
Monday, 13 March 2017
Facts about male breast cancer
1. Male breast cancer accounts for about one percent of all breast cancer.
2. High estrogen hormone and family history increase the risk of breast cancer in men.
3. A lump under the nipple is the most common symptom of male breast cancer.
4. Most cases of breast cancer in men develop in men who are 60 years and above.
5. Infiltrating ductal carcinoma is the most common type of male breast cancer.
6. About 85 percent of breast cancer in men have estrogen receptor on their cell membrane
7. A member of mutated genes have been linked to increase risk of male breast cancer.
8. Causes of male breast cancer is unknown
9. Early detection can prevent the spread of male breast cancer
10. Living healthy lifestyle can prevent male breast cancer.
Subscribe to:
Posts (Atom)